Zio AT ECG Monitoring System vs FibriCheck
AI Verdict
Choose Zio AT ECG Monitoring System if…
Choose Zio AT if your patient requires continuous, long-term (up to 14 days) ECG monitoring with real-time data transmission for comprehensive arrhythmia detection and diagnosis. This system is ideal when a clinician needs detailed, AI-powered analysis and comprehensive end-of-wear reports to identify complex or intermittent cardiac events that might be missed with shorter monitoring periods.
View Zio AT ECG Monitoring System →Choose FibriCheck if…
Choose FibriCheck if your patient needs a convenient, on-demand solution for frequent self-monitoring of their heart rhythm using just their smartphone. This app is best suited for patients who want to regularly screen for conditions like Atrial Fibrillation and track their heart health, providing immediate results and the ability to log other vital signs like blood pressure.
View FibriCheck →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Zio AT ECG Monitoring System | FibriCheck |
|---|---|---|
| Pricing | Contact for pricing | Subscription-based, with options for monthly or annual payments. prices vary by region and may be partly or fully covered by insurance or employer. |
| Deployment | Cloud-based (data analytics and clinician portal) | Cloud-based (private cloud). |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
TieZio AT offers a 'set it and forget it' approach with its wearable patch for continuous monitoring, which can improve patient compliance once applied. FibriCheck leverages the ubiquity of smartphones for accessible, on-demand measurements, requiring more active user participation. Both offer distinct usability benefits depending on patient preference and clinical context.
Clinical Value
Zio AT ECG Monitoring SystemZio AT provides continuous, high-fidelity ECG data for up to 14 days, which is considered the gold standard for comprehensive arrhythmia detection, including asymptomatic events. Its FDA-cleared deep-learned AI algorithm offers a more diagnostically robust dataset than FibriCheck's PPG-based, intermittent monitoring.
Pricing & Value
FibriCheckFibriCheck offers transparent and publicly disclosed pricing, including flexible subscription models and options for doctor-prescribed use, which provides clear value propositions to both patients and providers. Zio AT's pricing is not publicly disclosed, making it difficult to assess its value proposition without direct inquiry.
Enterprise Readiness
Zio AT ECG Monitoring SystemZio AT explicitly states a Business Associate Agreement (BAA) is in place, which is crucial for healthcare enterprises, and comes from iRhythm, a well-established leader in remote cardiac monitoring. This suggests robust enterprise-level support and integration capabilities.
Innovation
Zio AT ECG Monitoring SystemWhile FibriCheck's use of smartphone cameras for heart rhythm monitoring is innovative for accessibility, Zio AT's integration of a dedicated wearable for continuous, high-fidelity ECG recording over an extended period, coupled with its FDA-cleared deep-learned AI (ZEUS System) for comprehensive arrhythmia detection, represents a more advanced and clinically impactful technological innovation.
Support & Docs
Zio AT ECG Monitoring SystemZio AT provides comprehensive 'Instructions for Use' and Clinical Reference Manuals, along with patient and healthcare professional FAQs. Crucially, it offers a readily accessible customer service phone number for direct patient and clinician support and troubleshooting. FibriCheck also offers extensive documentation and email support, but Zio AT's prominent phone support gives it an edge.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Zio AT ECG Monitoring System | FibriCheck |
|---|---|---|
| Name | Zio AT ECG Monitoring System | FibriCheck |
| Company | iRhythm Technologies, Inc. | Qompium nv |
| Core Technology | Wearable Zio AT patch for continuous ECG recording | Smartphone camera-based PPG technology for heart rhythm measurement |
| Monitoring Duration/Method | Continuous, uninterrupted ECG recording for up to 14 days | Smartphone-based, on-demand heart rhythm measurement |
| Key Detected Conditions | Symptomatic and asymptomatic cardiac events | Atrial Fibrillation (AFib) and other arrhythmias |
| Clinician Interface | ZioSuiteu00ae clinician portal and mobile app for patient management and report interpretation | Healthcare professional portal/dashboard for patient monitoring |
Videos
Demos, reviews, and walkthroughs featuring Zio AT ECG Monitoring System and FibriCheck.
Frequently Asked Questions
More Comparisons
More matchups featuring Zio AT ECG Monitoring System or FibriCheck
Backers
Who funded each tool's parent company.